| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |